The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway

In the clinical setting, given the potential adverse effects of thiazolidinediones and biguanides, we often have difficulty in treatment that no other insulin sensitizers are available for use in type 2 diabetic mellitus (T2DM) patients. Tianmai Xiaoke Pian (TMXKP) is a traditional Chinese medicine...

Full description

Saved in:
Bibliographic Details
Main Authors: Nana Wang, Tiegang Li, Ping Han
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2016/9261259
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548930098823168
author Nana Wang
Tiegang Li
Ping Han
author_facet Nana Wang
Tiegang Li
Ping Han
author_sort Nana Wang
collection DOAJ
description In the clinical setting, given the potential adverse effects of thiazolidinediones and biguanides, we often have difficulty in treatment that no other insulin sensitizers are available for use in type 2 diabetic mellitus (T2DM) patients. Tianmai Xiaoke Pian (TMXKP) is a traditional Chinese medicine tablet, which is comprised of chromium picolinate, Tianhuafen, Maidong, and Wuweizi. To understand its mechanism of action on insulin resistance, TMXKP (50 mg/kg orally) was tested in T2DM rats (induced by a high-fat diet and streptozotocin). Eight weeks later, fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT) were performed. Area under the curve (AUC) and homeostatic model assessment of insulin resistance (HOMA-IR) were calculated, and PI3-K/AKT signal pathway-related genes and proteins were tested by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis in muscle, adipose, and liver tissues, respectively. TMXKP significantly reduced FBG, OGTT, AUC, and HOMA-IR in diabetic rats P<0.05. Furthermore, we also observed that TMXKP could significantly decrease IRS-1, IRS-2, PI3-K p85α, and AKT2 gene expression and also IRS-1, IRS-2, PI3-K, AKT2, and p-AKT2 protein expression levels P<0.05 in diabetic rats. These findings confirm that TMXKP can alleviate insulin resistance in T2DM rats through the PI3K/AKT pathway. Thus TMXKP appears to be a promising insulin sensitizer.
format Article
id doaj-art-fe1d598f240046e1b37ad7d5b0d64d19
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-fe1d598f240046e1b37ad7d5b0d64d192025-02-03T06:12:47ZengWileyJournal of Diabetes Research2314-67452314-67532016-01-01201610.1155/2016/92612599261259The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal PathwayNana Wang0Tiegang Li1Ping Han2Endocrinology Department, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaEmergency Department, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaEndocrinology Department, Shengjing Hospital of China Medical University, Shenyang 110004, ChinaIn the clinical setting, given the potential adverse effects of thiazolidinediones and biguanides, we often have difficulty in treatment that no other insulin sensitizers are available for use in type 2 diabetic mellitus (T2DM) patients. Tianmai Xiaoke Pian (TMXKP) is a traditional Chinese medicine tablet, which is comprised of chromium picolinate, Tianhuafen, Maidong, and Wuweizi. To understand its mechanism of action on insulin resistance, TMXKP (50 mg/kg orally) was tested in T2DM rats (induced by a high-fat diet and streptozotocin). Eight weeks later, fasting blood glucose (FBG) and oral glucose tolerance tests (OGTT) were performed. Area under the curve (AUC) and homeostatic model assessment of insulin resistance (HOMA-IR) were calculated, and PI3-K/AKT signal pathway-related genes and proteins were tested by reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis in muscle, adipose, and liver tissues, respectively. TMXKP significantly reduced FBG, OGTT, AUC, and HOMA-IR in diabetic rats P<0.05. Furthermore, we also observed that TMXKP could significantly decrease IRS-1, IRS-2, PI3-K p85α, and AKT2 gene expression and also IRS-1, IRS-2, PI3-K, AKT2, and p-AKT2 protein expression levels P<0.05 in diabetic rats. These findings confirm that TMXKP can alleviate insulin resistance in T2DM rats through the PI3K/AKT pathway. Thus TMXKP appears to be a promising insulin sensitizer.http://dx.doi.org/10.1155/2016/9261259
spellingShingle Nana Wang
Tiegang Li
Ping Han
The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
Journal of Diabetes Research
title The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
title_full The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
title_fullStr The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
title_full_unstemmed The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
title_short The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway
title_sort effect of tianmai xiaoke pian on insulin resistance through pi3 k akt signal pathway
url http://dx.doi.org/10.1155/2016/9261259
work_keys_str_mv AT nanawang theeffectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway
AT tiegangli theeffectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway
AT pinghan theeffectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway
AT nanawang effectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway
AT tiegangli effectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway
AT pinghan effectoftianmaixiaokepianoninsulinresistancethroughpi3kaktsignalpathway